All section Close
Zydus Cadila Launches "Cheapest" Version Of COVID-19 Drug Remdesivir In India
Writer: Navya Singh
Navya writes and speaks about matters that often do not come out or doesn’t see daylight. Defense and economy of the country is of special interest to her and a lot of her content revolves around that.
India, 13 Aug 2020 11:33 AM GMT
Editor : Prateek Gautam |
A free soul who believes that journalism, apart from politics, should stand for social cause and the environment.
Creatives : Abhishek M
" An engineer by profession, Abhishek is the creative producer of the team, graphic designing is his passion and travelling his get away. In more ways than one, he makes the content visually appealing."
"Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19," Cadila Healthcare Managing Director Dr Sharvil Patel said.
Zydus Cadila on August 13 launched the cheapest and the most affordable generic version of Gilead Sciences' antiviral drug, remdesivir, in India to treat coronavirus, after reports of scarcity of the drug at hospitals in India surfaced.
Zydus has priced it at ₹ 2,800 ($37.44) per 100mg vial and will be sold under the brand name 'Remdac' to government and private hospitals treating COVID-19 patients.
"Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19," Cadila Healthcare Managing Director Dr Sharvil Patel said.
Recently, several Indian states had complained of supply issues, however, a top executive at drugmaker Cipla had assured that the supplies were stabilising.
Zydus is the fifth company to launch another version of the antiviral drug in India after privately held Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences.
Gilead has also signed licensing agreements with Dr.Reddy's Laboratories and Syngene International to distribute remdesivir in 127 countries, including India.
Also Read: PM Narendra Modi Launches 'Transparent Taxation' Platform To Honour Honest Taxpayers
Must Reads
We are an independent and public-spirited digital media platform for Indian millennials. We report news and issues that matter as well as give you the opportunity to take action.
